BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12430546)

  • 1. [Comparison between two anti-motion sickness drugs].
    Wang J; Qian JK; Wang BZ; Gao JY; Shi HZ
    Space Med Med Eng (Beijing); 1999 Apr; 12(2):138-40. PubMed ID: 12430546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimotion sickness and antiemetic drugs.
    Wood CD
    Drugs; 1979 Jun; 17(6):471-9. PubMed ID: 467277
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of anti-motion sickness drugs on motion sickness in rats.
    Morita M; Takeda N; Kubo T; Yamatodani A; Wada H; Matsunaga T
    ORL J Otorhinolaryngol Relat Spec; 1988; 50(5):330-3. PubMed ID: 3186231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of drugs in altering susceptibility to motion sickness in aerobatics and the slow rotation room.
    Deane FR; Wood CD; Graybiel A
    Aerosp Med; 1967 Aug; 38(8):842-5. PubMed ID: 6049246
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of marezine and dramamine in preventing symptoms of motion sickness.
    Weinstein SE; Stern RM
    Aviat Space Environ Med; 1997 Oct; 68(10):890-4. PubMed ID: 9327113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Animal model of motion sickness in rats].
    Morita M
    Nihon Jibiinkoka Gakkai Kaiho; 1989 Sep; 92(9):1424-35. PubMed ID: 2585211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Model of motion sickness in dogs for assessing the effectiveness of pharmacological substances].
    Radkevich LA
    Kosm Biol Aviakosm Med; 1977; 11(6):50-3. PubMed ID: 22775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of sixteen anti-motion sickness drugs under controlled laboratory conditions.
    Wood CD; Graybiel A
    Aerosp Med; 1968 Dec; 39(12):1341-4. PubMed ID: 4881887
    [No Abstract]   [Full Text] [Related]  

  • 9. Various anti-motion sickness drugs and core body temperature changes.
    Cheung B; Nakashima AM; Hofer KD
    Aviat Space Environ Med; 2011 Apr; 82(4):409-15. PubMed ID: 21485398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Combination of Scopolamine and Psychostimulants for the Prevention of Severe Motion Sickness.
    Zhang LL; Liu HQ; Yu XH; Zhang Y; Tian JS; Song XR; Han B; Liu AJ
    CNS Neurosci Ther; 2016 Aug; 22(8):715-22. PubMed ID: 27160425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of ion-activated in situ gel systems of scopolamine hydrobromide and evaluation of its antimotion sickness efficacy.
    Cao SL; Zhang QZ; Jiang XG
    Acta Pharmacol Sin; 2007 Apr; 28(4):584-90. PubMed ID: 17376300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dramatic favorable responses of children with learning disabilities or dyslexia and attention deficit disorder to antimotion sickness medications: four case reports.
    Levinson HN
    Percept Mot Skills; 1991 Dec; 73(3 Pt 1):723-38. PubMed ID: 1686492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear medicine evaluation of motion sickness and medications on gastric emptying time.
    Wood MJ; Wood CD; Manno JE; Manno BR; Redetzki HM
    Aviat Space Environ Med; 1987 Nov; 58(11):1112-4. PubMed ID: 3318799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychophysiological aspects of motion sickness.
    Murray JB
    Percept Mot Skills; 1997 Dec; 85(3 Pt 2):1163-7. PubMed ID: 9450266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of the anti-motion sickness effect of 3-hydroxypyridine derivatives].
    Iasnetsov VV; Pravdivtsev VA; Shashkov AV; Smirnov LD; Iasnetsov VV; Kozlov SB; Ivanov IuV
    Aviakosm Ekolog Med; 2005; 39(4):45-50. PubMed ID: 16353627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel animal model for motion sickness and its first application in rodents.
    Yu XH; Cai GJ; Liu AJ; Chu ZX; Su DF
    Physiol Behav; 2007 Nov; 92(4):702-7. PubMed ID: 17612582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of efficacy of ginger with various antimotion sickness drugs.
    Wood CD; Manno JE; Wood MJ; Manno BR; Mims ME
    Clin Res Pr Drug Regul Aff; 1988; 6(2):129-36. PubMed ID: 11538042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of anti-cholinergic and cholinergic drugs on habituation to motion in rats.
    Morita M; Takeda N; Hasegawa S; Yamatodani A; Wada H; Sakai S; Kubo T; Matsunaga T
    Acta Otolaryngol; 1990; 110(3-4):196-202. PubMed ID: 2239207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prophylactic and sensitizing effects of biologically active substances in animal modeling of vestibular disorders].
    Shashkov VS; Drozd IuV; Puko VM
    Kosm Biol Aviakosm Med; 1991; 25(5):61-3. PubMed ID: 8577151
    [No Abstract]   [Full Text] [Related]  

  • 20. Expanded table: some drugs for altitude illness, jet lag, and motion sickness.
    Med Lett Drugs Ther; 2019 Oct; 61(1582):e161-e163. PubMed ID: 31599874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.